← brief for 2026-09-25 · Slowing decline

Evaluation of toll-like receptor inhibition by novel thymoquinone analogues as potential remedy for diabetic nephropathy.

Key takeaways

Researchers made 13 new versions of a compound called thymoquinone. They tested these in the lab to see if they could block a protein involved in kidney damage. The most promising version showed strong activity in the test tube. This is an early step and has not been tested in people yet.

Who did this work

Zaher NH · El-Hazek RMM · Mostafa MI

Source

Article · PubMed, CKD progression and prevention · 2026 Sep 25
https://pubmed.ncbi.nlm.nih.gov/42789034/